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ABSTRACT 
 
Sleep fragmentation and disturbances of normal circadian rhythms are inherent 
in the aging human population.  The rhesus macaque (Mucaca mulatta) exhibits 
similar disruption in sleep patterns and is a useful model to study these 
disturbances.  Orexin is an excitatory neuropeptide that has been implicated in 
the regulation of wakefulness and alertness.  Specifically, it has projections from 
its neuronal bodies in the lateral and perifornical hypothalamus to various 
forebrain and brainstem regions that control arousal state.  One of the regions of 
high innervation by these orexigenic neurons is the thalamus.  This study used a 
semi-quantitative means to determine if there are age dependent changes in 
Orexin innervation in the thalamus.  There was a general trend of decreasing 
axon density when analyzed with a novel semi-quantitative method (r = -0.515, p 
= 0.024, df = 17) and approached significance when assessed with a previously 
published method (r = -0.454, p = 0.0509, df = 17), indicating a decrease with 
age.  Additionally, there was no significant decrease in unilateral bouton counts 
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when examined with age using either method.  Although the findings in this study 
point to an age-related decrease in axon terminals, further research should 
examine the total orexigenic positive content in the thalamus to explain why 
bouton counts do not seem to change.  
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AAALAC Association for the Assessment and Accreditation of Laboratory 
Animal Care 
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BUMC Boston University Medical Center 
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fMRI  Functional Magnetic Resonance Imaging 
IACUC Institutional Animal Care and Use Committee 
KARN  1% Paraformaldehyde/1.25% Glutaraldehyde Fixative  
LC  Locus Coeruleus 
LHA  Lateral Hypothalamus 
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NIH  National Institute of Health 
OX1  Orexin 1 Receptor 
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OxA  Orexin A 
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1. Introduction 
Orexin, or hypocretin, is an excitatory neuropeptide mainly synthesized in 
neurons of the perifornical and lateral hypothalamus. It is synthesized as prepro-
Orexin which undergoes proteolytic cleavage into two forms, Orexin-A and 
Orexin-B.  These forms activate two different receptors, OX1 and OX2 (de 
Lecea, 1998; España and Scammel, 2011).  OX1 binds Orexin A with ten times 
the affinity of Orexin B, to the OX1 receptor while the OX2 receptor binds both 
Orexins A and B with equal affinity (de Lecea, 1998).   
Orexin producing hypothalamic neurons give rise to widespread 
projections in the forebrain and brainstem and affect many mechanisms critical 
for survival such as feeding, lipid homeostasis, male sexual behavior, 
wakefulness and alertness states, as well as reward pathways (Sakurai, 2006; 
Tsunematsu and Yamanaka, 2012; Muschamp, 2007; Skryzypski et al., 2011; 
Harris et al., 2005).  A characteristic cataplexic and narcoleptic phenotype in 
Orexin deficient humans led to a scrutinization of Orexin’s effects on wakefulness 
and alertness (Nishino, 2000).  The involvement of Orexin with the regulation of 
arousal and wakefulness led to many studies examining age dependent changes 
in the hypothalamus (Downs et al., 2007; Roberts et al, 2012; Kessler et al., 
2011).  Specifically, the rhesus macaque has been a useful model because of its 
similarity to humans as a diurnal primate (Balzamo et al., 1977).  They exhibit the 
same kind of sleep fragmentation in their geriatric population as humans 
(Zhadanova, 2011).  Behavioral assessments have been made, looking at 
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actogram activity levels, as well as circadian rhythms to try to correlate functional 
deficits with anatomical structures (Downs et al. 2006; Peters, 1996).  Downs 
assessed neuron number in the hypothalamus for Orexin B and reported no 
change with age.  In contrast, work of Roberts et al (in preparation) in this lab 
assessed Orexin A neuron numbers and found an age-related reduction only in 
male monkeys.  
Interestingly, Downs et al, 2006 also performed a semi-quantitative 
analysis of Orexin B axon density in the locus coeruleus and reported a decrease 
in fiber density as a function of age.  This latter finding was thought to reflect 
decreases in Orexin B levels even though neurons were not lost.  
The thalamus is also one of the regions richly innervated by Orexin 
neurons that may also play a role in arousal (Nambu et al., 1999; Portas, 1998).  
An age-related decline in cognitive function may be related to cortical and 
subcortical arousal deficiencies, which may themselves be limited by a decrease 
of Orexin innervation to the midline thalamus (Groenewegen, 1994; Schmidt, 
2012).  Previous studies have looked at Orexin as a mediator of the limbic 
forebrain arousal system, but have not related it with age (Kirouac, 2005).  More 
specifically, in humans, the thalamus has been examined as a mediator of 
attention and arousal, but only with fMRI studies (Schmidt, 2012).  The current 
study looks specifically at the midline thalamus in the rhesus macaque, and to 
examine more closely whether Orexin A fibers change as a function of age in an 
area that has not been investigated, namely the thalamus. 
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2. Methods 
2.1 Animals 
A total of 19 rhesus macaques (Mucaca mulatta), 12 males and 7 females, 
were utilized in this study (Table 1).  They ranged in age from 7.8 to 31 years old.  
All animals were part of a study on the neurological bases of age-related 
cognitive impairments and were obtained from Yerkes National Primate 
Research Center at Emory University (YNPRC).  Their medical records were 
screened for health problems, and initial physical exams were done to ensure 
that only healthy monkeys were included in this study.  Furthermore, MRIs were 
also acquired to ensure the absence of occult brain pathology.  These selected 
subjects went on to receive behavioral assessments of learning and memory 
while still at YNPRC.  Finally, the selected subjects were transferred to Boston 
University Medical Center (BUMC), where additional behavioral assessments 
were done for attention and executive function.  YNPRC and BUMC are both 
accredited by the Association for the Assessment and Accreditation of 
Laboratory Animal Care (AAALAC) and all procedures were approved by the 
Institutional Animal Care and Use Committees (IACUC) at YNPRC and at BUMC 
and conformed to NIH guidelines.  
2.2 Housing 
Animals were housed individually but were able to maintain visual and 
auditory contact with other monkeys.  Between the hours of 06:00h and 18:00h, 
lights were kept on within the colony rooms.  All of the animals were fed a 
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standard lab monkey chow supplemented with ample fruit, vegetables, nuts, and 
seeds.  In addition, water was available ad libitum.  The monkeys were fed either 
once immediately following a behavioral test, or twice daily if testing was not 
scheduled.  At the conclusion of behavioral assessments, all monkeys were 
deeply anesthetized with sodium pentobarbital (25mg/kg to effect) for a terminal 
in vivo neurophysiology study followed by perfusion-fixation of the brain with four 
liters of 4% paraformaldehyde in 0.1 M phosphate buffer, pH = 7.4, at a 
temperature of 37°C.  Following perfusion, the monkeys were necropsied to 
account for any presence of occult somatic disease processes that might alter 
normal brain physiology or animal behavior (Roberts, 2012). 
2.3 Tissue collection 
As soon as the monkeys were perfused, their brains were blocked in situ 
in the coronal stereotactic plane.  One hemisphere was then cryoprotected in a 
phosphate buffer solution containing 10% glycerol and 2% DMSO for two days.  
It was then moved to a 20% glycerol and 2% DMSO solution for three more days 
before it was flash frozen in isopentane at -75°C (Rosene et al., 1986).  Once 
frozen brains were kept at 80°C until sectioned on a freezing sliding microtome in 
the coronal stereotactic plane into nine total series.  There were eight series cut 
at a thickness of 30 µm, and one series cut at a thickness of 60 µm.  The brain 
sections were collected in phosphate buffer with 15% glycerol as cryoprotectant 
and stored at -80°C until processed for Orexin A immunohistochemistry. 
2.4 Immunohistochemistry 
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After an overnight thawing in a cold room at 4°C, the glycerol was 
removed from the free-floating sections by rinsing with a 0.1M phosphate buffer 
(pH 7.4).  The endogenous peroxidases were then quenched in a 1% hydrogen 
peroxide solution for 60 minutes.  Sections were then blocked in a solution 
consisting of 3% normal horse serum, 0.25% Triton-X 100 (Sigma), and 0.1M 
phosphate buffer for 60 minutes.  Sections were then placed in goat anti-OxA 
antibody (1:1000) (Santa Cruz Biotech, CA) for 18 hours at 4°C, followed by an 
immediate wash to separate the unbound antibodies.  The sections were then 
incubated at room temperature for 2 hours in biotinylated rabbit anti-goat IgG 
(1:500) (Vector Laboratories).  After the incubation, sections were washed and 
put in a peroxidase-conjugated avidin-biotin-complex (ABC complex, VectaStain 
standard kit, Vector Laboratories) for one hour.  Visualization of the Orexin A was 
made possible by a final incubation in a solution of 50 ml phosphate buffer, 50 
mg 3, 3’-diaminobenzidine tetrachloride (DAB), 125 µl 3% hydrogen peroxide 
solution for three minutes (Roberts et al., 2012).  After the staining was complete, 
the brain slices were mounted on gelatin subbed slides, air dried, dehydrated in a 
series of graded alcohol solutions, cleared with xylene, and cover slipped.  
To verify the specificity of the anti-OxA antibody, the antibody was pre-
absorbed for two hours with excess OxA peptide.  The pre-absorbed antibody 
was then used in the normal immunoassay protocol.  In addition, the specificity of 
the anti-goat IgG antibody was also assessed by omitting the primary antibody 
from the assay.  For both assessments, no staining was observed.   
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2.5 Image Acquisition 
All sections were scanned on a Nikon E600 microscope fitted with an ASI 
MS-2000 motorized stage, stage encoder for accurate z-axis measurements, and 
an Optronics analog video camera. Due to shrinkage after mounting, the original 
30 µm thick sections were reduced in the z-dimension to between 11.8 and 22.0 
µm, with the majority between 12.3 and 13.4 µm.  After delineating the 
boundaries of the diencephalon at low power, image acquisition was done with 
the 20X objective using Turboscan Surveyor system (Objective Imaging) 
software to acquire the images and create seamless photomontages.  These 
montages were then used to identify the reference space and perform 
quantification as described below. 
2.6 Reference Space 
Examination of the Orexin A photomontage of the diencephalon allowed 
the reference space to be defined. First, as shown in Figure 1a and 1b the 
thalamus was delineated by identifying four surrounding boundaries. The lateral 
boundary was the presence of the internal capsule.  The ventral boundary was 
the hypothalamus which was easily identified by the presence of stained 
neuronal bodies in addition to a different staining intensity.  In addition, the dorsal 
boundary was marked by the caudate, and the medial boundary was the third 
ventricle or the hemispheric bisection.  A macaque brain atlas was consulted if 
boundaries were at all ambiguous (Paxinos, 2000) as well as to identify the 
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midline and intralaminar nuclei (e.g. central medial, parafasicular, etc). These 
defined the reference space for quantification as shown in Figure 1c. 
2.7 Quantification 
To quantify OX-A positive axons and terminals, each section was sampled 
five times, with a minimum of three sections per animal.  A random number 
generator was used to randomize sampling of the delineated area and was 
obtained from Haahr (1998).  Once the images were scanned and digitized, they 
were quantified and processed using ImageJ according to two separate methods. 
2.7.1 Method 1  
The first method, adapted from Horvath 1999 and from Downs et al 2006, 
used a uniformly sized and regularly shaped grid that was created using two 
perpendicular sets of three parallel lines 120 µm long with the lines spaced 35 
µm apart which produced nine internal intersections.   In addition, this created an 
internal grid of four squares with dimensions of 35 x 35 µm. Outside of these 
squares, twelve gridlines extended 25 µm outside the grid following the internal 
gridlines (Figure 2a).  This sampling probe was positioned in five different 
locations in the reference space on the image based on x,y coordinates by the 
overlay function within ImageJ at 30% opacity, randomly selected with a random 
number generator.  This random number generator was also used to rotate the 
grid orientation from 1 - 360° at each placement.  The random number 
generator’s range was restricted to the pixel dimensions in the x- and y-axes of 
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each image.  Quantification of the number of axons was done by counting the 
number of times that an axon intersected with any line on the grid.   
To quantify the number of boutons, a 60 x 60 µm square was overlayed 
with random position and orientation on top of the image (Figure 2b).  The RGB 
images were converted into 8-bit images, which were then adjusted via 
thresholding to create an optimal binary image.  Thresholding is an internal 
function of ImageJ as well, and assigns a binary value to a pixel. The sensitivity 
and determination of the binary value is dependent on an automatically set 
threshold level.  The binary image can then be quantified via computerized 
particle counts and manually hand counted.  Juxtaposition of the binary image 
with the original RGB image prevented ambiguous quantification. Five squares 
were randomly placed within the reference space in total. Only whole boutons 
were counted, and boutons lying on the boundaries were excluded as well.  
Reuse of the random number generator to place a new coordinate for the test 
grids was necessary if an initial placement was on any of the borders of the 
thalamus where a test grid was incompletely overlayed on top of the reference 
space. 
2.7.2 Method 2 
Once the images were scanned and digitized, they were quantified and 
processed with ImageJ by placing a test grid over the image similarly to how 
Method 1 placed its grid.  A random number generator overlayed the 90 x 90 µm 
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square with random orientation and position on the midline thalamus reference 
space based on pixel dimensions of the reference space. The grid was 90 X 90 
µm on a side and consisted of nine 30 x 30 µm squares, with two of the four 
outer borders of the test grid in bold as “inclusion” boundaries (Figure 2c).  From 
the initial random placement, additional test grid locations were systematically 
selected based on the formula:   
x + nMx/3, y + nMy/3 where 
 Mx = Maximum x-axis dimensions 
 My = maximum y-axis dimensions 
 n = whole integers 
Additional test grids were added until the placements left the reference 
space. This systematic random sampling created intervals of sampling based on 
this formula and the overlayed pattern consisting of individual grids spanned the 
entire reference space. The additional test grids also maintained the same 
orientation as the original placement.  However, similar to Method 1, if the initial 
selected location was on the boundary of the reference space or incompletely 
overlayed, then a new position and orientation would be generated. The goal was 
to generate five random placements per section.  
Boutons were quantified within the grid using the top four right-most 
squares by counting how many boutons were present in the 3600 um2 area via 
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both thresholding and manual hand counting.  The effect of this was that the area 
of the thalamic reference space probed for boutons in Method 2 was identical to 
the area probed in Method 1. Axon density was quantified by counting the 
number of axons that intersected with both of the internal lines and the two bold 
outer boundary lines.   
2.7.3 Statistics 
To examine the similarity of Method 1 and Method 2, a paired sample t-
test was performed.  In addition, bivariate correlations between the methods 
were also run.  To assess the effect of age on boutons and axons, a bivariate 
correlation was performed on age against each method’s estimates of both axon 
terminal density and bouton quantity.  In addition, subjects were stratified into two 
groups: young adults (13 years of age and under) and old adults (25 years of age 
and older) and analyzed by independent t-test.  We had 12 males and 7 females 
in this study, but after assessment with ANOVA yielded no significance on either 
axon density or boutons, all males and females were pooled for subsequent 
analysis.  Statistics were run using SPSS 21.0.0 for Windows 7x64.  Values were 
considered significant at the α = 0.05 level, are reported below and presented in 
graphs as mean ± SEM.  
3. Results 
3.1 Methodology 
Both Method 1 and Method 2 yielded similar values in terms of axon 
density quantification.  There was a very strong and positive correlation between 
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the two methods (r = 0.888, p = 0.0001, df = 17; Figure 4).  Method 1 and Method 
2 were also positively correlated when quantifying bouton counts (r = 0.487, p = 
0.035, df = 17; Figure 5).  Regardless, values were still reported from both 
methods as a function of age. A paired samples t-test showed that the axon 
densities were not significantly different between methods (t = 1.156, p = 0.263, 
df = 17). However, the bouton counts were significantly different when analyzed 
with a paired samples t-test (t = 2.356, p = 0.030, df = 18) demonstrating that the 
results of Method 1 were 12.45% higher than Method 2. 
3.2 Axon Density 
 With regards to age, results from Method 1 showed a moderate, negative 
correlation between age and axon density, i.e. a reduction with age, that 
approached significance (r = -0.454, p = 0.0509, df = 17).  Similarly, Method 2 
also showed a moderate, negative, but significant correlation between age and 
axon density in the thalamus (r = -0.515, p = 0.024, df = 17). These correlations 
have very similar values, although Method 1 technically doesn’t reach 
significance (Figure 6). 
 The animals were also grouped into either young adults (13 years of age 
or younger, n = 6) or old adults (25 years of age or older, n = 4) and analyzed by 
independent t-test.  With Method 1, there was no significant difference in axon 
density between the two age groups (t = 1.569, df = 8, p = 0.155).  The mean 
axon density was determined to be 18.714 ± 2.599 in young adults and 13.408 ± 
1.191 in the old adults (Figure 7).  However, when quantified with Method 2, 
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there was a significant difference in unilateral axon density between young and 
old age groups (t = 2.3516, df = 8, p = 0.047).  The mean axon density was 
determined to be 18.389 ± 2.202 in the young adults and 11.102 ± 1.801 in the 
old adults (Figure 7).  
3.3 Bouton Counts 
  As shown in Figure 8, age had no significant correlation with bouton 
density when quantified with either Method 1 (r = 0.213, p = 0.381, df = 17) or 
Method 2 (r = -0.115, p = 0.526, df = 17). Similarly, as shown in Figure 9, when 
the animals were grouped into young adults (13 years of age or younger, n = 6) 
and old adults (25 years of age or older, n = 4), analysis by independent t-test 
confirmed that there was no significant difference in unilateral bouton density 
between age groups with Method 1 (t = 0.657, p = 0.530, df = 8) or with Method 2 
(t = 2.358, p = 0.265, df = 8). Young adult bouton counts were determined as 
13.765 ± 1.231 using Method 1, while with Method 2 they were 12.655 ± 1.338. 
In addition, Method 1 determined that old adult bouton counts were 14.982 ± 
1.301, while Method 2 bouton counts were 10.298 ± 1.315. 
3.4 Gender Differences 
 Since the gender of the subjects was available, the data was also 
examined for differences between gender and for both axon density and bouton 
density.  As shown in Figure 10, there was no significant difference between 
males and females on axon counts for either Method 1 (p = 0.8113, t = 0.243, df 
= 17) or Method 2 (p = 0.738, t = 0.34, df = 17). The mean axon density, while 
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using Method 1, for females was 17.175 ± 1.573 and males was 17.786 ± 1.683. 
Method 2’s axon terminals were determined to be 17.462 ± 2.261 for females 
and 16.517 ± 1.664 for males. Similarly in Figure 11, no significant difference 
was found in bouton counts for either Method 1 (p = 0.684, t = 0.414, df = 17) or 
Method 2 (p = 0.367, t = 0.926, df = 17). The mean bouton counts for females 
were 15.053 ± 0.755 and males were 14.536 ± 0.84 when using Method 1. 
Finally, the mean bouton counts for females were 14.01 ± 1.405 for females and 
12.564 ± 0.87 for males. 
4. Discussion 
4.1 Methodology 
 The axon density and bouton count quantification methods previously 
described by Horvath (1999) constitutes a semi-quantitative means to estimate 
axon density based on the number of intersections of grid lines that intersect 
axons and the number of boutons present within a given sampling area. This is 
essentially the method used by Downs et al (2006) to quantify Orexin B in the 
locus coeruleus of monkeys.  The alternative test grid we created for Method 2 
was designed to use a consolidated means to quantify both entities, while 
maintaining systematic random sampling.  
As stated, a primary goal for the creation of the test cross was to maintain 
the original dimensions as much as possible described by Horvath.  Axon density 
was quantified by Horvath using two perpendicular sets of 3 parallel lines, 
measuring 120 µm in length.  Six sets of lines are present, with a total length of 
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720 µm (Figure 2).  Similarly, Method 2’s test grid consists of two perpendicular 
sets of four lines.  However, since it is a semi-quantitative density that is being 
measured, a smaller 90 µm square with eight intersecting lines would 
overestimate axon density.  To correct for this, only three lines are used, which 
are selected based on the original orientation of the test grid.  The dimension that 
we were measuring, a unit per area measurement or density, is dependent on 
the area of the test grid.   Changes in length of a single dimension in the test grid 
would have to be proportional to a change in the area. Since the reduction of the 
line is decreased by 25%, an equivalent 25% decrease in area must be met.  A 
35 x 35 µm internal grid area and 120 µm line lengths were used in Method 1; a 
30 x 30 µm internal grid area and 90 µm line lengths were used in Method 2.  
The reduction in the line’s length 0f 30 µm is met with a similar proportional 
reduction in area.  The internal grid area of 1225 µm2 was proportionally reduced 
to a 900 µm2 area, which is a 26.53% decrease.   
In addition, bouton density in Horvath’s original method was determined 
explicitly using a 60 x 60 µm square.  Method 2 maintains the 3600 µm2 
dimensions by utilizing four 900 µm2 squares within the test grid.  Although the 
actual area in Method 2 is preserved from the same as Method 1, there was only 
a medium strength correlation between the two methods (r = 0.487, p = 0.035, df 
= 17; Figure 5).  The same essential probing squares had a weaker correlation 
than the test cross, and this may be attributed to the non-significant results from 
bouton counts.  
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The high correlation of the two methods indicates that using either method 
will return similar results. However, because Method 2 uses a much more 
succinct probe, it is much easier to apply and a lot more time efficient.  
The most pronounced difference in methodologies is that Method 1 
maintains complete random sampling, while Method 2 utilizes systematic random 
sampling.  Method 1 randomly samples five times per section, while Method 2 
attempts to maintain the same number of samples, and the similarity of the 
results indicate that the axon terminals that are present in the midline thalamus 
are evenly spread out.  The selection of additional points uses a formula that 
looks at maximum axis dimension divided by three in order to adhere to roughly 
the same number of samples that Method 1 uses.   
  Next, a more strict definition of “randomly placed” was added to ensure 
reproducibility.  A random number generator would be able to place the position 
in (x,y) coordinates on the digital image, which are essentially pixel coordinates.  
It was not clear from Horvath’s study how placement maintained randomness.  
Random orientation was simply a rotation of the test grid around a central pivot 
anywhere between 1-360 degrees.  Orientation made a difference in what was 
being quantified in Method 2 because of the use of only three of the four lines.  It 
was also not clear in Horvath’s study if there was only hand-counting used for 
quantifying the boutons; however, for the present study, thresholding was utilized 
in order to obtain a more accurate quantification.  The ability to juxtapose an 
image that has been thresholded with the original image to obtain bouton counts 
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provided a more precise means in quantifying boutons (Figure 3).  Each bouton 
is numbered automatically, and comparing the original RGB image with the 
created binary image allowed manual recognition of each bouton present in a 
given sampling area. 
 Finally, two of the original animals were removed from the study because 
of their perfusion with PFA/GLU. They were omitted because they were statistical 
outliers; their diminished intensity may not have affected previous studies utilizing 
them for cell counts, but because in our study we determined bouton counts and 
axon terminals by staining intensity, the PFA/GLUT perfused animals showed 
significantly decreased staining and were removed. 
4.2 Age Effects 
 Horvath (1999) quantified Orexin axon density and bouton number in the 
locus coeruleus, to contrast it with other brain areas in the macaque, but age was 
not considered.  Then, Downs et al. (2006) conducted a semi-quantitative 
analysis of only axon density locus coeruleus as well as an analysis of cell 
numbers in the hypothalamus of the aging macaque.  They reported that even 
though there was no change in the number of Orexin-B positive neurons in the 
hypothalamus, there was a significant decrease in axon density in the locus 
coeruleus of the older age group (25 years of age and older).  As show in Figure 
6, when we used a similar semi-quantitative method (Method 1) to quantify axon 
density in the thalamus, we found an age-related reduction that only 
“approached” significance (p = 0.0509). However, when we utilized Method 2, we 
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found a reduction that was significant at p = 0.024 (Figure 6).  This may be due to 
two factors.  First, the absolute number of Orexin fibers in the thalamus is much 
less than that found in the locus coeruleus.  Downs reported that their “old aged” 
group of monkeys had a mean number of axon intersections of 112.4 ± 3.9; we 
report a value of 13.408 ± 1.191 using the same method (Figure 7).  If there were 
any effects of age, there might not be a statistically significant difference, but still 
a functional difference, with a one order of magnitude decrease of fibers.  
Second, Downs used immune-reactive Orexin-B, while we utilized Orexin-A.  
Although these two molecules should be co-localized in the soma, there are 
instances in which visualization might vary in the actual axonal projections.  A 
study found that there were age-dependent decreases in axonal transport in rats 
(Cross, 2008).  Additionally, in rats, there is a differential distribution of Orexin-A 
and Orexin-B fibers.  Orexin-B was found to be visualized much less in the 
paraventricular nucleus of the thalamus than Orexin-A (Cutler et al., 1999).  The 
significant decrease in axon density that Downs discovered may be accounted 
for by an unequal age-related decrease in both Orexin-A and Orexin-B axonal 
transport, as well as a decreased visualization of Orexin-B in areas like the 
paraventricular nucleus of the thalamus in this study. 
 It is interesting to note that using Method 2 does yield a statistically 
significant difference in axon density while Method 1 does not when contrasting 
the age groups (Figure 6).  The similarity in the quantification ability of Method 2 
and Method 1 might indicate usage of either method to quantify axonal density.  
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Again, the arbitrary designation of a 0.05 significance level could still indicate a 
functional difference since we found a significance at p = 0.0509.  Downs et al. 
also had a larger range of subjects available, as their study’s subjects were <1 to 
32 years of age. Their stratification of age groups into young pre-pubertal (2-4 
years; n = 5), adult (9-13 years; n = 4), and old (25-32 years; n = 4) showed that 
there was an age related change only between the young pre-pubertal and old 
groups.  We used the same stratification comparing the adult and old age groups 
to similarly find no significant difference while using Method 1. The significant 
difference that we see with Method 2 may indicate that this may be marginally 
insignificant, and clarification would be necessary with additional research 
looking into the third young, pre-pubertal age group in the thalamus.   
Boutons do not appear to be affected by age at all, with regards to either 
Method 1 or Method 2 (Figure 8).  There were a consistent number of boutons 
per 3600 um2 area across both age groups (Figure 8).  While there have been no 
previous studies semi-quantitatively examining bouton count in the aging 
macaque, it would have been assumed that bouton counts would decrease if 
axon density were also decreasing.  However, since we found an approaching 
significant decrease in axon fibers with Method 1, we would expect to see a 
similar maintenance of bouton counts. Regardless, the trend that axon terminals 
seems to be decreasing while bouton counts are maintained should indicate a 
further investigation into total orexigenic positive content in the midline thalamus. 
4.3 Gender Effects 
 19 
 Since the data for gender was available, it was examined along with age 
for main effect and interaction effects.  The findings of this study point to no 
gender-related effects on either axon density or bouton counts with regards to 
Orexin-A fibers. 
 
5. Conclusions 
 While the fragmentation in circadian rhythms and sleep seen in aging 
macaques has brought questions of Orexin’s unique role in regulating 
wakefulness and alertness, there must be more done to examine the full role of 
the noradrenergic system in conjunction with Orexin to understand the role of the 
thalamus’s Orexinergic projections.  The thalamus receives a robust innervation 
of Orexinergic fibers, but is ancillary to that of the locus coeruleus.  It would be 
important to conduct a study that compared age dependent changes of both 
Orexin A and Orexin B localization in both the thalamus and locus coeruleus in 
the same subjects with the same methods.   
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Figure 1: Reference Space Delineation.  
Sequence of obtaining desired reference space 
within the thalamus. (a) Entire thalamus is visibly 
identified under 20x objective. (b) Borders of 
thalamus are delineated.  (c) Desired reference 
space is attained; its darker staining can be 
contrasted to the lateral portions (uncircled) of the 
thalamus. 
 21 
 
Figure 2: Quantification Probes.  Sample test 
grids are placed with random orientation and 
position in the reference space.  (a) Method 1 
uses a test grid composed of two 
perpendicular sets of parallel 120 micrometer 
lines, forming a test cross. The lines on the 
test cross that are intersecting with axon 
terminals are counted. A rotational orientation 
of 33° is shown (b) Method 1 also uses a test 
square to quantify the number of boutons 
present in a 60 micrometer squared area, 
counting only whole boutons that are not 
touching the borders of the test square.  A 
rotational orientation of 97° is shown.  (c) 
Method 2 combines both elements from the 
two separate test grids in Method 1.  To 
determine quantities of axon terminals, the 
lines that intersect with the two internal lines 
and the bold line will be counted.  In addition, 
the central squares of the outermost 8 
squares will be counted for bouton quantity.  
A rotational orientation of 169° is shown. 
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Figure 3:  Thresholding.  The process of 
quantifying boutons in Method 1 uses 
thresholding. (a) The unaltered, 
unmodified image has a visible lone axon 
with boutons. (b) The test square is placed 
on this area, encircling the axon.  The red 
highlighted area shows the areas that 
were detected by thresholding. (c) 
conversion of the 8-bit image into a binary 
image allows for quick quantification.  
Ambiguous boutons in the binary image 
can be easily juxtaposed with the original 
image to ensure quantification accuracy.  
For example, the blot labeled with ‘1’ 
would not be considered a bouton 
because it is visibly not a part of any axon. 
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Method 2 
Axon Density Method Contrast 
Figure 4: Unilateral Axon density Method Contrast Scatterplot.  A scatterplot 
contrasting the two methods used to quantify unilateral axon density.  Method 
1 is plotted on the y-axis, while Method 2 is plotted on the x-axis.  These 
methods showed a strong and significant positive correlation when used to 
measure unilateral axon density (r = 0.888, p = 0.0001, df = 17).  Significance 
was considered at the α=0.05 level. 
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Method 2 
Bouton Count Method Contrast 
Figure 5: Unilateral Bouton Count Method Contrast Scatterplot.  A scatterplot 
contrasting the two methods used to quantify unilateral axon density.  Method 
1 is plotted on the y-axis, while Method 2 is plotted on the x-axis.  These 
methods showed a moderately strong and significantly positive correlation as 
well (r = 0.487, p = 0.035, df = 17).  Significance was considered at the 
α=0.05 level. 
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Age Effects on Synaptic Axon Density 
Method 2
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Figure 6: The effects of increasing age on the unilateral synaptic axon density in macaques 
show a mild, negative but not significant correlation by using Method 1 (r = -0.454, p = 
0.051,df = 17).  Likewise, when using Method 2, a similar mild, negative and significant 
correlation is seen (r = -0.515, p = 0.024, df = 17) 
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Figure 7: Age Effects on Unilateral Axon Density Bar Graph.  Each group 
consisted of an age-specific range of monkeys.  Young adults (7-13 years of 
age) and old adults are contrasted (25 years of age and older) via 
quantification using both Methods 1 and 2.  Using Method 1 showed young 
adults with a mean unilateral axon density of 18.71438 ± 2.599, while old 
adults showed a mean unilateral axon density of 13.408 ± 1.191.  There was 
no significance at the α=0.05 level(p = 0.1553, t = 1.569, df = 8).  However, 
when using Method 2 to quantify mean unilateral axon density in both age 
groups, there was a significant difference (p = 0.0466, t = 2.352, df  = 8)) at 
the α=0.05 level.  Mean unilateral axon density in young adults was 18.389 ± 
2.202; in old adults, the mean unilateral axon density was determined to be 
11.102 ± 1.301. 
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Figure 8: Age Effects on Unilateral Bouton Counts Scatterplot.  When examining the effects of 
age on unilateral bouton counts, there is a very weak and not significant correlation by 
Method 1 (r = 0.213, p = 0.381, df = 17). Similarly, when using Method 2, there is a very weak 
and not significant correlation as well (r = -0.155, p = 0.526, df = 17). 
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Age Effects On Bouton Counts 
 
Young Adult
Old Adult
Figure 9: Each group consisted of an age-specific range of monkeys.  Young 
adults (7-13 years of age) and old adults are contrasted (25 years of age and 
older) via quantification using both Methods 1 and 2.  First, using Method 1 
showed that the young adults had a mean unilateral bouton density of 13.764 
± 1.231.  In addition, it was also determined that the old adults had a mean 
unilateral bouton count of 14.982 ± 1.301.  Second, using Method 2 showed 
that the young adults had a mean unilateral bouton count of 12.655 ± 1.338, 
and the old adults had a mean unilateral bouton count of 10.298 ± 1.315.  
Finally, there was no significant difference between young adults and old 
adults when using either Method 1 (p = 0.53, t = 0.657, df = 8) or Method 2 (p 
= 0.266, t = 2.358, df  = 8) to examine unilateral bouton counts at the α=0.05 
level. 
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Males
Figure 10: Gender Effects on Unilateral Axon Density Bar Graph.  The effects 
of gender on unilateral axon density are examined.  First, quantities were 
determined via Method 1.  Females had a mean unilateral axon density of 
17.175 ± 1.573, while males had a mean axon density of 17.786 ± 1.683.  
There was no significant difference of unilateral axon density based on 
gender while using Method 1 (p = 0.811, t = 0.243, df = 17).  Next, axons 
were examined via Method 2. Females had a mean axon density of 17.462 ± 
2.261, while males had a mean axon density of 16.517 ± 1.664.  Again, there 
was no significant difference between males and females in axon density (p = 
0.738, t = 0.34, df = 17). 
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Figure 11: Gender Effects on Unilateral Bouton Count Bar Graph.  The effects 
of gender on unilateral axon density are examined.  First, quantities were 
determined via Method 1.  Females had a mean unilateral bouton count of 
15.053 ± 0.755, while males had a mean unilateral bouton density of 14.536 ± 
0.84.  Next, quantities were examined via Method 2.  Females had a mean 
bouton count of 14.009 ± 1.405, while males had a mean of 12.564 ± 0.87.  
Again, there was no significant difference in unilateral bouton density 
between males and females using Method 1 (p = 0.684, t = 0.414, df = 17) or 
Method 2 (p = 0.367, t = 0.926, df = 17). 
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Animal 
ID 
Age Sex Age Group Hemisphere Fixative 
AM198 7.8 F Young Adult R 4% PFA 
BM85 8.1 M Young Adult R 4% PFA 
AM229 8.3 M Young Adult R 4% PFA 
AM138 12 M Young Adult R 4% PFA 
AM195 12.1 F Young Adult R 4% PFA 
AM137 12.6 M Young Adult L 4% PFA 
AM239 17.9 M Middle Aged R 4% PFA 
AM190 18 F Middle Aged R 4% PFA 
AM233 19 M Middle Aged R 4% PFA 
AM153 19.4 M Middle Aged R 4% PFA 
AM216 19.7 M Middle Aged R 4% PFA 
AM149 19.8 F Middle Aged R 4% PFA 
AM162 22.3 F Middle Aged R 4% PFA 
AM189 24.5 M Middle Aged R 4% PFA 
AM064 24.9 M Middle Aged R 4% PFA 
AM110 25.8 M Old Adult R 4% PFA 
AM181 27.5 F Old Adult R 4% PFA 
AM121 30.2 M Old Adult R 4% PFA 
AM119 31 F Old Adult R 4% PFA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: PFA = Paraformaldehyde 
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Animal 
ID 
Method 1 
Terminal 
Density 
Method 2 
Terminal 
Density 
Method 
1 Bouton 
Count 
Method 2 
Bouton 
Count 
AM198 15.85 16.35 14.35 12.2 
BM85 21.133 20.933 8.733 8.8 
AM229 28.2 26.12 15.32 15.68 
AM138 14.1333 10.6667 14.467 9.8 
AM195 22.3 20.9 17.55 17.25 
AM137 10.67 15.367 12.16667 12.2 
AM239 26.4 24.7 17.5 17.2 
AM190 22.4 27.133 17.4 19.933 
AM233 24.6 22.9 16.2 12.15 
AM153 15.733 14.333 13.6 15.75 
AM216 15.629 14.943 11 10.8 
AM149 14.267 14.8 14.267 12.867 
AM162 17.867 19.933 15.867 15.067 
AM189 13.9 14.75 13.4 12.75 
AM064 16.943 12.2 18.06 15.2 
AM110 12.96 8.12 18.12 7.44 
AM181 16.64 15.12 12.04 12 
AM121 13.133 13.167 15.867 13 
AM119 10.9 8 13.9 8.75 
 
Table 2: Quantified values obtained from each individual 
animal is shown contrasting both methods. 
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